Kolexia
Chirio David
Médecine interne
Hôpital De l'Archet
Nice, France
59 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Endocardite Bactériémie Infections communautaires Hépatite Thrombophilie Syndrome des anticorps antiphospholipides Embolie Syndrome coronarien aigu

Industries

ViiV Healthcare
20 collaboration(s)
Dernière en 2023
MSD
14 collaboration(s)
Dernière en 2023
Adliva
14 collaboration(s)
Dernière en 2021
B3TSI
7 collaboration(s)
Dernière en 2023

Dernières activités

CoVInnate: Role of Inflammasomes in COVID-19 Disease
Essai Clinique (CHU Nice)   20 mars 2023
24/7 workflow for bloodstream infection diagnostics in microbiology laboratories: the first step to improve clinical management.
Clinical chemistry and laboratory medicine   04 novembre 2022
Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification.
Journal of clinical medicine   08 juin 2022
Correlations between Persistent Olfactory and Semantic Memory Disorders after SARS-CoV-2 Infection.
Brain sciences   31 mai 2022
Déjà plus de 200 patients atteints de Covid long sont passés par le CHU ...
France Bleu   24 mars 2022
What about using sniffin' sticks 12 items test to screen post-COVID-19 olfactory disorders?
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery   30 octobre 2021
COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France.
Scientific reports   16 septembre 2021
Prise en charge du COVID LONG - Dr David Chirio, infectiologue au CHU de Nice - 4 février 2021
Youtube @ Communauté interhospitalière Paca Est CIPE   28 mars 2021
Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity.
Blood advances   16 mars 2021
Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department: Caracterisation of SARS-Cov2 Infected Patients Hospitalized in Infectious Disease Department
Essai Clinique (CHU Nice)   01 mars 2021